Precision AQ
Chloe WangSenior Consultant
Chloe Wang specializes in global pricing and market access strategy with a strong focus on APAC markets. She advises pharmaceutical clients on pricing, reimbursement, and access decisions, translating cross-market insights into actionable strategies to support global launch and lifecycle management. Chloe has extensive experience across Japan, China, and broader APAC, as well as Europe and the Middle East, spanning oncology, cardiovascular, neurology, autoimmune, and rare diseases. Her work includes international reference pricing and launch sequencing, price modelling, evidence generation strategy, and value communication, as well as emerging areas such as AI-enabled payer engagement and MFN strategy. Chloe holds an MSc in International Health Management from Imperial College London and a BSc in Pharmaceutical Sciences from Tianjin University.
Insights from Chloe Wang
Commercialization & Access | White Paper
China Market Access After NRDL Maturity: What Comes After the Price Reset?
NRDL inclusion is no longer the finish line. See why reimbursement alone doesn’t guarantee real-world utilization.